Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Granules India Ltd.
Swot
Granules India Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Granules India Ltd. has 19 Strengths, 8 Weaknesses, 4 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(19)
Weakness
(8)
Opportunity
(4)
Threats
(1)
Others
(2)
Benjamin Graham Value Screen
Consistent Highest Return Stocks over Five Years
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Companies with Low Debt
Increasing Revenue every quarter for the past 3 quarters
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
High Volume, High Gain
Stocks in uptrend most likely to cross above SMA-200 soon
Top Gainers
High Volume, High Gain
Volume Shockers
Promoter decreasing their shareholding
Companies with growing costs YoY for long term projects
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Degrowth in Revenue and Profit
Declining Net Cash Flow : Companies not able to generate net cash
Increasing Trend in Non-Core Income
Stocks Underperforming their Industry Price Change in the Quarter
Brokers upgraded recommendation or target price in the past three months
Street Favorite: High Analyst Rating with at least 20% upside
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
US FDA Warning Letter
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)